At a glance
ClinicalIndex Comparison RecordN/ACompleted· 204 enrolled
Drug / intervention
Diabetes Medication Choice decision aidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Diabetes Medication Choice Cards Trial in Greece
In Brief
A clinical study evaluating Diabetes Medication Choice decision aid for Diabetes Mellitus, Type 2. Completed, enrolled 204 participants across 8 sites.
Detailed Summary
A cluster randomized trial to assess the efficacy of the Diabetes Medication Choice decision aid among Greek patients with type 2 diabetes mellitus compared with usual care. The tool will serve as a facilitator for the Shared Decision Making process.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesGreece
CollaboratorsEuropean Foundation for the Study of Diabetes, Mayo Clinic
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedMay 2013
Primary CompletionFeb 2014
Study CompletionAug 2014
TodayJul 2026
First PostedMay 24, 2013
Enrollment StartMay 1, 2013
Primary CompletionFeb 1, 2014
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.1 years ago
Interventions
Diabetes Medication Choice decision aidother
The Diabetes Medication Choice decision aid cards provide information about medications commonly used to treat type 2 diabetes mellitus. The tool was originally developed and successfully evaluated by Mayo Clinic researchers.